Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Elena P Calandre, Fernando Rico-Villademoros & Mahmoud Slim. (2015) An update on pharmacotherapy for the treatment of fibromyalgia. Expert Opinion on Pharmacotherapy 16:9, pages 1347-1368.
Read now
Read now
Kim Francis Le Marshall & Geoffrey Owen Littlejohn. (2011) Management strategies for fibromyalgia. Open Access Rheumatology: Research and Reviews 3, pages 47-51.
Read now
Read now
Matthias F Seidel & Wolfgang Müller. (2011) Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists. Expert Opinion on Pharmacotherapy 12:9, pages 1381-1391.
Read now
Read now
Michael Spaeth. (2010) Fibromyalgia Syndrome Treatment from a Multidimensional Perspective. Journal of Musculoskeletal Pain 18:4, pages 373-379.
Read now
Read now
Emma Guymer & Geoffrey Littlejohn. (2009) Fibromyalgia: current diagnosis and management. Expert Review of Clinical Immunology 5:2, pages 181-192.
Read now
Read now
Roland Staud. (2007) Treatment of fibromyalgia and its symptoms. Expert Opinion on Pharmacotherapy 8:11, pages 1629-1642.
Read now
Read now
Andrew J Thompson & Sarah CR Lummis. (2007) The 5-HT3 receptor as a therapeutic target. Expert Opinion on Therapeutic Targets 11:4, pages 527-540.
Read now
Read now
J. J. H. Chen, J. Y. Wang, Y. M. Chang, S. Y. Su, C. T. Chang, S. S. Sun, C. H. Kao & C. C. Lee. (2007) Regional cerebral blood flow between primary and concomitant fibromyalgia patients: a possible way to differentiate concomitant fibromyalgia from the primary disease. Scandinavian Journal of Rheumatology 36:3, pages 226-232.
Read now
Read now
Rebecca L Robinson & Megan L Jones. (2006) In search of pharmacoeconomic evaluations for fibromyalgia treatments: a review. Expert Opinion on Pharmacotherapy 7:8, pages 1027-1039.
Read now
Read now
Articles from other publishers (39)
Pothuri R Ram, Madhan Jeyaraman, Naveen Jeyaraman, Arulkumar Nallakumarasamy, Manish Khanna, Ashim Gupta & Sankalp Yadav. (2023) Beyond the Pain: A Systematic Narrative Review of the Latest Advancements in Fibromyalgia Treatment. Cureus.
Crossref
Crossref
Helen Irving, Ilona Turek, Christine Kettle & Nor Yaakob. (2021) Tapping into 5-HT3 Receptors to Modify Metabolic and Immune Responses. International Journal of Molecular Sciences 22:21, pages 11910.
Crossref
Crossref
Rodrigo Oliveira Mascarenhas, Mateus Bastos Souza, Murilo Xavier Oliveira, Ana Cristina Lacerda, Vanessa Amaral Mendonça, Nicholas Henschke & Vinícius Cunha Oliveira. (2021) Association of Therapies With Reduced Pain and Improved Quality of Life in Patients With Fibromyalgia. JAMA Internal Medicine 181:1, pages 104.
Crossref
Crossref
Semanur Özdel, Esra Bağlan & Mehmet Bülbül. (2020) Evaluation of patients presenting with leg pain to the pediatric rheumatology polyclinic: A single center experience. Ortadoğu Tıp Dergisi 12:2, pages 181-185.
Crossref
Crossref
Akash Pandhare, Aneesh Satya Pappu, Henrik Wilms, Michael Paul Blanton & Michaela Jansen. (2017) The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors. Neuropharmacology 113, pages 89-99.
Crossref
Crossref
Steven Chinn, William Caldwell & Karina Gritsenko. (2016) Fibromyalgia Pathogenesis and Treatment Options Update. Current Pain and Headache Reports 20:4.
Crossref
Crossref
Gary W. Jay & Robert L. Barkin. (2015) Fibromyalgia. Disease-a-Month 61:3, pages 66-111.
Crossref
Crossref
Rodrigo Arreola, Enrique Becerril-Villanueva, Carlos Cruz-Fuentes, Marco Antonio Velasco-Velázquez, María Eugenia Garcés-Alvarez, Gabriela Hurtado-Alvarado, Saray Quintero-Fabian & Lenin Pavón. (2015) Immunomodulatory Effects Mediated by Serotonin. Journal of Immunology Research 2015, pages 1-21.
Crossref
Crossref
A. A. Spasov & D. S. Yakovlev. (2013) 5-HT3 Receptors as Targets for Biologically Active Compounds (Review). Pharmaceutical Chemistry Journal 47:8, pages 399-404.
Crossref
Crossref
Claudia Sommer, Winfried Häuser, Rieke H. F. Alten, Franz Petzke, Michael Späth, Thomas Tölle, Nurcan Üçeyler, Andreas Winkelmann, Eva Winter & Karl-Jürgen Bär. (2013) Das Fibromyalgiesyndrom: Was hilft wirklich?. CME 10:6, pages 61-74.
Crossref
Crossref
Li Zhang & Wei Xiong. 2013. endoCANNABINOIDS. endoCANNABINOIDS
199
218
.
C. Sommer, W. Häuser, R. Alten, F. Petzke, M. Späth, T. Tölle, N. Üçeyler, A. Winkelmann, E. Winter & K.J. Bär. (2012) Medikamentöse Therapie des FibromyalgiesyndromsDrug therapy of fibromyalgia syndrome. Der Schmerz 26:3, pages 297-310.
Crossref
Crossref
Alban Y. Neziri, Martina Dickenmann, Pasquale Scaramozzino, Ole K. Andersen, Lars Arendt-Nielsen, Anthony H. Dickenson & Michele Curatolo. (2012) Effect of intravenous tropisetron on modulation of pain and central hypersensitivity in chronic low back pain patients. Pain 153:2, pages 311-318.
Crossref
Crossref
Anatoly A. Mazurov, Jason D. Speake & Daniel Yohannes. (2011) Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators. Journal of Medicinal Chemistry 54:23, pages 7943-7961.
Crossref
Crossref
Pascale Vergne‐Sallel, Carine Dufauret‐Lombardl, Christine Bonnetl, Anne Simonl, Richard Trèvesl, Henri Bonnabaul & Philippe Bertinl. (2012) A randomised, double‐blind, placebo‐controlled trial of dolasetron, a 5‐hydroxytryptamine 3 receptor antagonist, in patients with fibromyalgia. European Journal of Pain 15:5, pages 509-514.
Crossref
Crossref
Philip J. Mease, Kelly Dundon & Piercarlo Sarzi-Puttini. (2011) Pharmacotherapy of fibromyalgia. Best Practice & Research Clinical Rheumatology 25:2, pages 285-297.
Crossref
Crossref
Javier Rivera Redondo. (2011) Tratamiento farmacológico en la fibromialgia. Seminarios de la Fundación Española de Reumatología 12:1, pages 21-26.
Crossref
Crossref
BaoXi Gao, Markus Hierl, Kristie Clarkin, Todd Juan, Hung Nguyen, Marissa van der Valk, Hong Deng, Wenhong Guo, Sonya G. Lehto, David Matson, Jeff S. McDermott, Johannes Knop, Kevin Gaida, Lei Cao, Dan Waldon, Brian K. Albrecht, Alessandro A. Boezio, Katrina W. Copeland, Jean-Christophe Harmange, Stephanie K. Springer, Annika B. Malmberg & Stefan I. McDonough. (2010) Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain. Pain 149:1, pages 33-49.
Crossref
Crossref
Claudia Sommer. 2010. Handbook of the Behavioral Neurobiology of Serotonin. Handbook of the Behavioral Neurobiology of Serotonin
457
471
.
Emma Guymer & Geoffrey O. Littlejohn. 2010. Muscle Pain: Diagnosis and Treatment. Muscle Pain: Diagnosis and Treatment
105
141
.
Lesley M. Arnold. (2009) Strategies for Managing Fibromyalgia. The American Journal of Medicine 122:12, pages S31-S43.
Crossref
Crossref
Tatiana Reitblat, Doron Zamir, Ilia Polishchuck, Galina Novochatko, Stephen Malnick & Leonid Kalichman. (2009) Patients treated by tegaserod for irritable bowel syndrome with constipation showed significant improvement in fibromyalgia symptoms. A pilot study. Clinical Rheumatology 28:9, pages 1079-1082.
Crossref
Crossref
Philip J. Mease & Ernest H. Choy. (2009) Pharmacotherapy of Fibromyalgia. Rheumatic Disease Clinics of North America 35:2, pages 359-372.
Crossref
Crossref
Dawn A. Marcus. (2009) Fibromyalgia: Diagnosis and treatment options. Gender Medicine 6, pages 139-151.
Crossref
Crossref
Christine N. HuynhLeanne M. YanniLaura A. Morgan. (2008) Fibromyalgia: Diagnosis and Management for the Primary Healthcare Provider. Journal of Women's Health 17:8, pages 1379-1387.
Crossref
Crossref
C. Sommer, W. Häuser, M. Berliner, W. Brückle, S. Ehlers, K. Mönkemöller, B. Moradi, F. Petzke, N. Üçeyler, R. Wörz, E. Winter & D.O. Nutzinger. (2008) Medikamentöse Therapie des FibromyalgiesyndromsPharmacological treatment of fibromyalgia syndrome. Der Schmerz 22:3, pages 313-323.
Crossref
Crossref
Ramesh Balasubramaniam, Joel M. Laudenbach & Eric T. Stoopler. (2007) Fibromyalgia: an update for oral health care providers. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 104:5, pages 589-602.
Crossref
Crossref
W. Müller, M. Schneider, T. Joos, H.Y. Hsu & T. Stratz. (2007) Ein Modell zur Einteilung des FibromyalgiesyndromsSubgroups of fibromyalgia. Der Schmerz 21:5, pages 424-429.
Crossref
Crossref
Gualberto Ruaño, Paul D. Thompson, Andreas Windemuth, Richard L. Seip, Amit Dande, Alexey Sorokin, Mohan Kocherla, Andrew Smith, Theodore R. Holford & Alan H. B. Wu. (2007) Physiogenomic association of statin-related myalgia to serotonin receptors. Muscle & Nerve 36:3, pages 329-335.
Crossref
Crossref
Matthias F. Seidel, Gunter F. Weinreich, Thomas Stratz & Wolfgang Müller. (2007) 5-HT3 receptor antagonists regulate autonomic cardiac dysfunction in primary fibromyalgia syndrome. Rheumatology International 27:11, pages 1025-1030.
Crossref
Crossref
W. Müller, E. M. Schneider & T. Stratz. (2007) The classification of fibromyalgia syndrome. Rheumatology International 27:11, pages 1005-1010.
Crossref
Crossref
Fabiola Rostro, María J Cancelo & Camil Castelo-Branco. (2007) Pain in fibromyalgia patients. Therapy 4:2, pages 193-200.
Crossref
Crossref
Gerhard Fürst. (2007) Das Fibromyalgie-Syndrom: eine interdisziplinäre Herausforderung – Verlegenheitsdiagnose, Volksseuche oder Modekrankheit?Fibromyalgia – A challenge for interdisciplinary management. Wiener Medizinische Wochenschrift 157:1-2, pages 27-33.
Crossref
Crossref
Adrian Miranda, Shachar Peles, Peter G. McLean & Jyoti N. Sengupta. (2006) Effects of the 5-HT3 receptor antagonist, alosetron, in a rat model of somatic and visceral hyperalgesia. Pain 126:1, pages 54-63.
Crossref
Crossref
Kathryn Baker & Andre Barkhuizen. (2006) Pharmacologic treatment of fibromyalgia. Current Psychiatry Reports 8:6, pages 464-469.
Crossref
Crossref
W. Müller, B. L. Fiebich & T. Stratz. (2006) 5-HT3-Rezeptor-Antagonisten als Analgetika bei rheumatischen Erkrankungen5-HT3 receptor antagonists als analgetics in rheumatic diseases. Zeitschrift für Rheumatologie 65:6, pages 546-552.
Crossref
Crossref
A. Brautbar, D. Elstein, B. Pines, N. Krienen, J. Hemmer, D. Buskila & A. Zimran. (2006) Fibromyalgia and Gaucher's disease. QJM: An International Journal of Medicine 99:2, pages 103-107.
Crossref
Crossref
Cayetano Alegre de Miquel, Claudia Alejandra-Pereda, María Betina-Nishishinya & Javier Rivera. (2005) Revisión sistemática de las intervenciones farmacológicas en la fibromialgia. Medicina Clínica 125:20, pages 784-787.
Crossref
Crossref
Kathryn Baker & Andre Barkhuizen. (2005) Pharmacologic treatment of fibromyalgia. Current Pain and Headache Reports 9:5, pages 301-306.
Crossref
Crossref